Engineers Gate Manager LP Sage Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $5.42 Billion
- Q4 2024
A detailed history of Engineers Gate Manager LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 34,552 shares of SAGE stock, worth $255,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,552
Previous 84,537
59.13%
Holding current value
$255,684
Previous $609,000
69.29%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding SAGE
# of Institutions
194Shares Held
45MCall Options Held
304KPut Options Held
117K-
Black Rock Inc. New York, NY5.22MShares$38.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$35.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$34 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$33 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$22.2 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $440M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...